USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
X-IN8 BIOLOGICALS CORPORATION
Address:
741 PINEHURST DRIVE
CHAPEL HILL, NC 27517-
Phone:
N/A
URL:
N/A
EIN:
126443547
DUNS:
829921225
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $291,826.00 1
STTR Phase I $321,746.00 1

Award List:

The effect of TLR4 inhibition on lung transplant ischemia-reperfusion injury

Award Year / Program / Phase:
2010 / STTR / Phase I
Award Amount:
$321,746.00
Agency:
HHS
Principal Investigator:
Perry A. Genova – 919-619-0388
Research Institution:
University Of North Carolina Chapel Hill
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): Ischemia-reperfusion injury (IRI) occurs in organs when circulation is interrupted, causing ischemia, and then ischemic tissue is reperfused. This leads to a series of biologic consequences, resulting in edema and inflammation. IRI is a significant problem in… More

TLR4 Inhibition to Reduce Cerebral Ischemia Reperfusion Injury

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$291,826.00
Agency:
HHS
Principal Investigator:
M. N. Ellis – 919-619-0388
Abstract:
DESCRIPTION (provided by applicant): ABSTRACT Interruption and subsequent restoration of circulation in tissues causes varying amounts of ischemia- reperfusion injury (IRI). IRI is a detrimental feature of many clinical events such as organ transplants, cardiopulmonary bypass (CPB) used in… More